Your browser version may not work well with NCBI's Web applications. More information here...
1: Neuropsychiatr Dis Treat. 2008 Aug;4(4):723-30.Click here to read Links

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents.

Canitano R, Scandurra V.

Division of Child Neuropsychiatry, University Hospital of Siena Siena, Italy.

This is a review of the clinical trials investigating the efficacy and safety of risperidone in the treatment of children with autistic spectrum disorders (ASD). The main clinical characteristics are impairment in social skills, communication difficulties, repetitive movements and behaviors, including stereotypies. Pharmacotherapy is mainly directed at the so-called target symptoms, ie, behavioral disorders and the various kinds of repetitions associated with ASD. According to the available data, risperidone seems to be moderately efficacious and safe for treating behavioral disorders. 4 double blind controlled trial. 3 reanalysis studies, and 12 open studies have documented the role of risperidone in children with ASD. Controlled studies have been thoroughly considered in this review.

PMID: 19043516 [PubMed - in process]

PMCID: PMC2536539

Patient Drug Information

  • Risperidone (Risperdal® , Risperdal® M-TAB® )

    Risperidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and teenagers 13 years of ...

  • Source: AHFS Consumer Medication Information